Use of natalizumab in multiple sclerosis: current perspectives.

•  
• Overview
•  
• Research
•  
• Identity
•  
• Additional Document Info
•  
• View All
•  

Overview

authors

• Gandhi, Sirin
• Dejan Jakimovski MD, PhD
• Ahmed, Rahil
• Hojnacki, David
• Kolb, Channa
• Weinstock-Guttman, Bianca
• Zivadinov, Robert

publication date

• January 1, 2016

published in

• Expert opinion on biological therapy  Journal

has subject area

• Animals
• Antibodies, Monoclonal
• Antibodies, Monoclonal, Humanized
• Clinical Trials as Topic
• Disease Progression
• Humans
• Immunologic Factors
• Leukoencephalopathy, Progressive Multifocal
• Multiple Sclerosis
• Natalizumab

Research

Keywords

• MRI
• Multiple sclerosis
• brain atrophy
• disability progression
• monoclonal antibodies
• natalizumab
• progressive multifocal leukoencephalopathy
• relapse rate

Identity

Digital Object Identifier (DOI)

• https://doi.org/10.1080/14712598.2016.1213810

PubMed ID

• 27413840

Additional Document Info

start page

• 1151

end page

• 62

volume

• 16

issue

• 9